As of 4:00pm ET
| -0.025 / -3.91%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 13.00 and a low estimate of 3.25. The median estimate represents a +875.45% increase from the last price of 0.62.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.